StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright reaffirmed a neutral rating and set a $1.00 price target on shares of Cytosorbents in a research report on Friday, March […]